Drugs' scarcity strains care: Cancer patients may be affected - El Paso Times
Shortages of drugs used to treat everything from leukemia to black widow spider bites
are putting patients at risk -- nationally and more recently in El Paso. And there
appears to be no long-term solution in sight.
... Although drug shortages have been a problem since the 1990s, the scarcity of cancer treatment drugs has worsened in the last year, said Dr. Zeina Nahleh, chief of the Division of Hematology-Oncology in the Texas Tech Paul L. Foster School of Medicine's Department of Internal Medicine. The only good news is that, so far, neither Nahleh nor Robert Reilly, University Medical Center associate pharmacy director, are aware of harm to patients in the El Paso area. |
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Recognized for Commitment to Improving Experiences and Advancing Outcomes for First-Generation College Students
FirstGen Forward announced TTUHSC is a new member of the FirstGen Forward Network Class of 2026. FirstGen Forward selected TTUHSC because the university demonstrated a commitment to improving experiences and advancing success for first-generation college students.
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease
A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.
TTU System Board of Regents Approves Appointment of Grover E. Murray Professor
The Texas Tech University System Board of Regents today (Aug. 13) approved the appointment of Rodney Young, M.D., from the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, as a Grover E. Murray Professor.